tadalafil has been researched along with leucyl-leucyl-leucine in 1 studies
Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (leucyl-leucyl-leucine) | Trials (leucyl-leucyl-leucine) | Recent Studies (post-2010) (leucyl-leucyl-leucine) |
---|---|---|---|---|---|
1,742 | 392 | 1,089 | 18 | 0 | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoyagi, T; Eguchi, K; Furuichi, I; Hida, A; Hirai, Y; Honda, S; Ida, H; Kamachi, M; Kawabe, Y; Kawakami, A; Koji, T; Migita, K; Nakamura, H; Nakashima, T; Yamasaki, S | 1 |
1 other study(ies) available for tadalafil and leucyl-leucyl-leucine
Article | Year |
---|---|
Importance of NF-kappaB in rheumatoid synovial tissues: in situ NF-kappaB expression and in vitro study using cultured synovial cells.
Topics: Antibodies, Monoclonal; Apoptosis; Arthritis, Rheumatoid; Carbolines; Caspase 3; Caspases; Cell Nucleus; Cells, Cultured; Enzyme Activation; fas Receptor; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Interleukin-1; NF-kappa B; Oligopeptides; Phosphodiesterase Inhibitors; Proliferating Cell Nuclear Antigen; Proteins; Stimulation, Chemical; Synovial Membrane; Tadalafil; Tumor Necrosis Factor-alpha; Viral Proteins; X-Linked Inhibitor of Apoptosis Protein | 2001 |